Abstract
Functionally, the CNS consists of a sensory and motor system, and both usually collaborate with each other for proper functions. Structurally, it consists of the brain located in the cranial cavity and the spinal cord located in the vertebral canal. Generally, the brain occupies approximately 2% of the total body weight. It expends approximately 20% of the total oxygen inhaled through the respiratory system and expends roughly 25% of the D-glucose ingested through the GI system. Thus, the brain is one of the organs generating oxygen free radicals most vigorously so that some apparatus for its protection from oxidative damages should be inevitable. The organ containing the highest concentration of vitamin C in the body is the brain. The average concentration of vitamin C in the human peripheral blood is approximately 40~60 μM. However, its concentration in the neuronal cytoplasm reaches approximately 10 mM, about 200 times as high as the human serum concentration. The cytoplasmic concentration of vitamin C in astrocytes or microglial cells, which usually consume 20% of the total amount of oxygen neurons consume, is about 1~2 mM suggesting that the concentration of vitamin C in brain cells seems to be closely related to the consumption amount of oxygen. Vitamin C may play a critical role in CNS development, especially in the development of the cerebellum. Additionally, we also observed defects in motor function upon vitamin C deficiency. We presented morphological evidence for the defects in motor function with atrophic changes of the granule cells and Purkinje cells in the adult cerebellum of Gulo(−/−) mice upon vitamin C deficiency. Conclusively, vitamin C deficiency during gestation may induce intraparenchymal hemorrhages and severe defects in the development of the cerebellum. Several neurodegenerative disorders such as Alzheimer disease, Parkinson disease, and Huntington disease are known to be closely related with ROS in terms of their pathogenesis. Dementia is a general designation of mental deterioration. Parkinson disease is a slowly progressive disease characterized by several motor dysfunctions such as a masklike face, a characteristic tremor of the resting muscles, a slowing of voluntary movements, a festinating gait, a peculiar posture, and weakness of the muscles. Considering again the relationship between the oxygen consumption proportion (20%) of neurons and the extremely high concentration of vitamin C (10 mM) in the neuronal cytoplasm, oxidative stress seems to have an essential role in this disease process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agus DB, Gambhir SS, Pardridge WM, Speilholz C, Baselga J, Vera JC. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest. 1997;100:2842–8.
Angelow S, Haselbach M, Galla HJ. Functional characterization of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells. Brain Res. 2003;988:105–13.
Atlante A, Gagliardi S, Minervini GM, Ciotti MT, Marra E, Calissano P. Glutamate neurotoxicity in rat cerebellar granule cells: a major role for xanthine oxidase in oxygen radical formation. J Neurochem. 1997;68:2038–45.
Berger UV, Lu XC, Liu W, Tanf Z, Slusher BS, Hediger MA. Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT-2 in rat brain. J Neurochem. 2003;86:896–906.
Ciani E, Groneng L, Voltattorni M, Rolseth V, Contestabile A, Paulsen RE. Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons. Brain Res. 1996;728:1–6.
Dhigra D, Parle M, Kulkarni SK. Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J Med Food. 2006;9:281–3.
Engelhart MJ, Geerings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287:3223–9.
Garcia ML, Salazar K, Millan C, Rodriguez F, Montecinos H, Caprile T, Silva C, Cortes C, Reinicke K, Vera JC, Aguayo LG, Olate J, Molina B, Nualart F. Sodium vitamin C cotransporter SVCT 2 is expressed in hypothalamic glial cells. Glia. 2005;50:32–47.
Grunewald RA. Ascorbic acid in the brain. Brain Res Rev. 1993;18:123–33.
Hakvoort A, Haselbach M, Galla HJ. Active transport properties of porcine choroid plexus cells in culture. Brain Res. 1998;795:247–56.
Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97(6):1634–58.
Hediger MA. New view at vitamin C. Nat Med. 2002;8:445–6.
Hillered L, Persson L, Bolander HG, Hallstrom A, Ungerstedt U. Increased extracellular levels of ascorbate in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. Neurosci Lett. 1988;95:286–90.
Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol. 1999;41:895–906.
Hornig D. Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann N Y Acad Sci. 1975;258:103–18.
Hosoya K, Minamizono A, Katayama K, Terasaki T, Tomi M. Vitamin C transport in oxidized form across the rat blood-brain barrier. Invest Ophalmol Vis Sci. 2004;45:1232–9.
Huang J, Agus DB, Winfree CJ, Kiss S, Mack WJ, McTaggart RA, Choudhri TF, Kim LJ, Mocco J, Pinsky DJ, Fox WD, Israel RJ, Boyd TA, Golde DW, Connolly ES Jr. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A. 2001;98:11720–4.
Huang J, May JM. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res. 2006;1097:52–8.
Hughes RE, Hurley RJ, Jones PR. The retention of ascorbic acid by guinea-pig tissues. Br J Nutr. 1971;26:433–8.
Kim H, Kim Y, Bae S, Lim SH, Jang M, Choi J, Jeon J, Hwang YI, Kang JS, Lee WJ. Vitamin C deficiency causes severe defects in the development of the neonatal cerebellum and in the motor behaviors of Gulo −/− mice. Antioxid Redox Signal. 2015;23:1270–83.
Lee JY, Chang MY, Park CH, Kim HY, Kim JH, Son H, Lee YS, Lee SH. Ascorbate-induced differentiation of embryonic cortical precursors into neurons and astrocytes. J Neurosci Res. 2003;73:156–65.
MacGregor DG, Higgins MJ, Jones PA, Maxwell WL, Watson MW, Graham DI, Stone TW. Ascorbate attenuates the systemic kainite-induced neurotoxicity in the rat hippocampus. Brain Res. 1996;727:133–44.
Mack WJ, Mocco J, Ducruet AF, Laufer I, King RG, Zhang Y, Guo W, Pinsky DJ, Connolly ES Jr. A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery. 2006;59:383–8.
Majewska MD, Bell JA, London ED. Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res. 1990;537:328–32.
Majewska MD, Bell JA. Ascorbic acid protects neurons from injury induced by glutamate and NMDA. Neuroreport. 1990;1:194–6.
May JM, Asard H. Ascorbate recycling. In: Asard H, May JM, Smirnoff N, editors. Vitamin C, functions and biochemistry in animals and plants. London: Bios Scientific Publishers; 2004. p. 139–58.
May JM, Jayagopal A, Qu ZC, Parker WH. Ascorbic acid prevents high glucose-induced apoptosis in human brain pericytes. Biochem Biophys Res Commun. 2014;452(1):112–7.
May JM, Li L, Hayslett K, Qu ZC. Ascorbate transport and recycling by SH-SY5Y neuroblastoma cells: response to glutamate toxicity. Neurochem Res. 2006;31:785–94.
May JM. Vitamin C transport and its role in the central nervous system. Subcell Biochem. 2012;56:85–103.
Montine T, Neely M, Quinn J, Beal M, Markesbery W, Roberts L, Morrow J. Lipid peroxidation in aging brain and Alzheimer’s disease. Free Radic Biol Med. 2002;33:620–6.
Morris MC, Beckett LA, Scherr PA, Hebert LE, Bennett DA, Field TS, Evans DA. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:121–6.
Mun GH, Kim MJ, Lee JH, Kim HJ, Chung YH, Chung YB, Kang JS, Hwang YL, Oh SH, Kim JG, Hwang DH, Shin DH, Lee WJ. Immunohistochemical study of the distribution of sodium dependent vitamin C transporters in adult rat brain. J Neurosci Res. 2006;83:919–28.
Nagayama H, Mamamoto M, Ueda M, Nito C, Yamaguchi H, Katayama Y. The effects of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin Neuropharmacol. 2004;27:270–3.
Pratico D. Alzheimer’s disease and oxygen radicals: new insights. Biochem Pharmacol. 2002;63:563–7.
Qiu L, Li L, Weeber EJ, May JM. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res. 2006.
Ranzan A, Theodore D, Haran RP, Chandy MJ. Ascorbic acid and focal cerebral ischemia in a primate model. Acta Neurochir. 1993;123:87–91.
Rebec GV, Pierce RC. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol. 1994;43:537–65.
Rebec GV, Barto SJ, Marseilles AM, Collins K. Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport. 2003;14:1263–5.
Rebec GV, Barton SJ, Ennis MD. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington’s disease gene. J Neurosci. 2002;22:RC202.
Rice ME, Lee EJ, Choy Y. High levels of ascorbic acid, not glutathione, in the CNS of anoxia-tolerant reptiles contrasted with levels in anorexia-intolerant species. J Neurochem. 1995;64:1790–9.
Rice ME, Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience. 1998;82:1213–23.
Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000;23:209–16.
Riviere S, Birlouez-Aragon I, Nourhashemi F, Bellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry. 1998;13:749–54.
Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velazquez M, Martinez-Barboza G, Acosta-Martinez JP, Ortiz GG. Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid beta peptide in rat brain: a comparative, in vivo study versus vitamin C and Eur. J Pineal Res. 2003;35:80–4.
Schippling S, Kontush A, Arit S, Buhmann C, Sturenburg HJ, Mann U, Muller-Thomsen T, Beisiegel U. Increased lipoprotein oxidation in Alzheimer’s disease. Free Radic Biol Med. 2000;28:351–60.
Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med. 1977;296:1393–8.
Wagner GC, Carelli RM, Jarvis MF. Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion. Neuropharmacology. 1986;25:559–61.
Wilson JX, Peters CE, Sitar SM, Daoust P, Gelb AW. Glutamate stimulates ascorbate transport by astrocytes. Brain Res. 2000;858:61–6.
Wilson JX. Antioxidant defense of the brain: a role for astrocytes. Can J Physiol Pharmacol. 1997;75:1149–63.
Yusa T. Increased extracellular ascorbate release reflects glutamate re-uptake during the early stage of reperfusion after forebrain ischemia in rats. Brain Res. 2001;897:104–13.
Zhang SM, Hernan MA, Chen H, Spiegelman D, Willett WC, Ascherio A. Intakes of vitamin E and C, vitamin supplements, and PD risk. Neurology. 2002;59:1161–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature B.V.
About this chapter
Cite this chapter
Lee, W.J. (2019). Central Nervous System (CNS) . In: Vitamin C in Human Health and Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1713-5_6
Download citation
DOI: https://doi.org/10.1007/978-94-024-1713-5_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1711-1
Online ISBN: 978-94-024-1713-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)